1.
Terblanche J, Saunders SJ, Louw JH. Prolonged palliation in carcinoma of the main hepatic duct junction. Surgery 1972;71:720–31.
2.
Bailey ME. Endotoxin, bile salts and renal function in obstructive jaundice. Br J Surg 1976;63:774–8.
3.
Bornman PC, Marks IN, Girdwood AH et al. Is pancreatic duct obstruction or stricture a major cause of pain in calcific pancreatitis? Br J Surg 1980;67:425–8.
4.
Northover JMA, Terblanche J. A new look at the arterial supply of the bile duct in man and its surgical implications. Br J Surg 1979;66:379–84.
5.
Hatfield ARW, Tobias R, Terblanche J, Girdwood AH, Fataar S, Harries-Jones R, Kernoff L, Marks IN. Pre-operative external biliary drainage in obstructive jaundice: a prospective controlled clinical trial. Lancet 1982;2:896–9.
6.
Terblanche J, Kahn D, Campbell JAH, Bornman PC, Jonker MAT, Wright J, Kirsch RE. Failure of repeated injection sclerotherapy to improve long-term survival after oesophageal variceal bleeding. A five-year prospective controlled clinical trial. Lancet 1983;2:1328–32.
7.
Bornman PC, Terblanche J. Subtotal cholecystectomy: for the difficult gallbladder in portal hypertension and cholecystitis. Surgery 1985;98:1–6.
8.
Bornman PC, Harries-Jones EP, Tobias R, van Stegmann G, Terblanche J. Prospective controlled trial of transhepatic biliary endoprosthesis versus bypass surgery for incurable carcinoma of head of pancreas. Lancet 1986;1: 69–71.
9.
Kitano S, Terblanche J, Kahn D, Bornman PC. Venous anatomy of the lower oesophagus in portal hypertension: practical implications. Br J Surg 1986;73:525–31.
10.
Krige JEJ, Bornman PC, Harries-Jones EP, Terblanche J. Modified hepaticojejunostomy for permanent biliary access. Br J Surg 1987;74:612–3
11.
Funnell IC, Bornman PC, Weakley SP, Terblanche J, Marks IN. Obesity: an important prognostic factor in acute pancreatitis. Br J Surg 1993;80:484–6.
12.
Madden MV, Krige JEJ, Bailey S, Beningfield SJ, Geddes C, Werner ID, Terblanche J. Randomised trial of targeted chemotherapy with lipiodol and 5-epidoxorubicine compared with symptomatic treatment for hepatoma. Gut 1993;34:1598–600.